Crenguta
Danila
a,
Michael
Bolte
b and
Volker
Böhmer
*a
aFachbereich Chemie und Pharmazie, Abteilung Lehramt Chemie, Johannes Gutenberg-Universität, Duesbergweg 10-14, D-55099, Mainz, Germany. E-mail: vboehmer@mail.uni-mainz.de
bInstitut für Organische Chemie, Johann Wolfgang von Goethe Universität, Marie Curie-Straße 11, D-60439, Frankfurt/Main, Germany
First published on 26th November 2004
General strategies are described to synthesize calix[4]arenes which are fixed in the 1,3-alternate conformation and substituted selectively by amino groups. These derivatives are useful starting materials for the attachment of various groups via amide bonds, as demonstrated by several examples, but may be converted also to ureas, imides or azomethines. Four amino groups may be attached to the narrow rim via (several) methylene groups as spacer by O-alkylation with ω-bromophthalimides or ω-bromonitriles. From the resulting tetraethers the amino functions are obtained by cleavage with hydrazine or by hydrolysis, allowing a selective functionalisation of both sides of the molecule (phenolic units A, C versus B, D). Amino functions at the wide rim are introduced by ipso-nitration of the respective t-butylcalix[4]arene derivatives and subsequent reduction. Selective ipso-nitration of a 1,3-diether, followed by O-alkylation with allylbromide to obtain the tetraether in the 1,3-alternate conformation, hydrogenation of allyl and nitro groups (in one step), protection of the amino functions as phthalimides followed by ipso-nitration of the remaining t-butyl phenol rings, allows again to distinguish both sides of the molecule (units A, C versus B, D). Reaction of a wide rim tetraamine in the 1,3-alternate conformation by Boc-anhydride allows not only to obtain the mono- and tri-Boc derivative, but also in nearly 60% yield the C2-symmetrical di-Boc derivative, in which two adjacent phenolic units are protected (distinction of A, B from C, D). This paves the way for the preparation of chiral derivatives or assemblies. O-Alkylation with ω-bromophthalimides followed by ipso-nitration leads to precursors for octaamines in the 1,3-alternate conformation, in which the potential amino functions on both rims can be selectively “activated” by reduction or hydrazinolysis. The structures of the newly synthesized molecules were mainly confirmed by their 1H NMR spectra, which allow a distinction from isomeric derivatives in the cone and partial cone conformation. Single crystal X-ray analyses were obtained for two analogous derivatives in the 1,3-alternate conformation (27, n = 3,4), an isomeric compound in the cone conformation (27, n = 3,4), and a derivative in the partial cone conformation (11).
Via the syn-1,3-diether 2 or 3, obtained in excellent yield in the presence of K2CO3, (or under Mitsunobu conditions in the case of 2 (n = 2) a mixed tetraether 4, fixed (mainly) in the 1,3-alternate conformation is available if the second etherification is done with an excess of Cs2CO327 as base. The amount of Cs2CO3 required as template can vary between 8- and 15-fold, with respect to the hydroxyl groups, depending on the nature of the existing ether residue and the p-substituent in the phenolic unit (see below). Partialcone and cone isomers28 are always observed as side products. The formation of tetraethers with four identical ether residues (e.g. alkylphthalimides), can be achieved in one step with Cs2CO3, but two steps, as outlined in Scheme 1, are preferable according to our experience.
![]() | ||
Scheme 1 (i) Alkyl bromide, K2CO3; (i′) for n = 2: N-(β-hydroxyethylphthalimide, triphenylphosphine, DIAD, THF; (ii) alkyl bromide, Cs2CO3, DMF, 50 °C; (iii) H2, Raney-Ni, NaOH; (iv) hydrazine, EtOH, reflux; (v) Ac2O; (vi) p-nitrobenzoylchloride. |
Compounds of type 4 contain two different precursors for amino functions which are in principle “orthogonal”. The cleavage of the phthalimido groups with hydrazine in refluxing ethanol occurs without reduction of the nitrile functions. As an example, diamine 5 was obtained in 88% yield. After acetylation of the amino functions (92% of 6) the reduction of the nitrile groups is possible by hydrogenation (Raney-Ni, room temperature) under alkaline conditions. In the final step a different residue may be attached to the diamine 7, as shown by the p-nitrobenzamide 8 chosen as an example.
Contrary to our expectations the reduction of the nitrile functions in 4 was not possible without a partial hydrolysis of one of the phthalimido groups. Under various conditions, e.g. lowering the temperature from 50 °C to room temperature, replacing Raney-Ni by Pd/C, using LiOH as weaker base instead of NaOH, the monophthalamide 9 was formed and isolated in yields up to 62%.29 Attempts to hydrogenate the nitrile functions with Raney-Ni in toluene at 60 °C left the starting material unreacted.30
However, the sequence 1 to 8 as outlined in Scheme 1 and realized for one example allows in principle to attach two different residues in alternate sequence to amino groups on the narrow rim of a 1,3-alternate calix[4]arene. Evidently diamines and their derivatives are available analogously.31
Selective ipso-nitration of syn-1,3-diethers, however, is possible in good yield in the phenolic units.18O-Alkylation of 10, taken as an example for such a dinitro-diether, with allylbromide leads to 11 in the 1,3-alternate conformation (accompanied by the partial cone isomer). Simultaneous reduction of the nitro groups and hydrogenation of the CC double bonds (Raney-Ni, rt) gives the diamine 12, in which the amino groups can be protected as phthalimide (13). Ipso-nitration of the t-butylphenyl ether units in 13 is possible in a clean fashion (without attack on the phthalimide units).20 In the special case we even found conditions (high dilution) to obtain the mono-nitro compound 14 in 79% yield, which could be used to synthesize wide rim triamines. Subsequent ipso-nitration of 14 gave the dinitro compound 15 in 83% yield. Compounds of type 14 and 15 contain two independent (orthogonal) precursors of amino groups. In analogy to similar derivatives in the cone-conformation20,33 either the phthalimide group can be cleaved by hydrazine (16) or the nitro groups can be hydrogenated (17). All steps are summarized in Scheme 2.
Thus, derivatives with two different amide residues are available from 15 (or 14) by deprotection (or reduction), acylation, reduction (or deprotection) and final acylation. The appropriate reaction sequence may be chosen with respect to the special example.
It should be mentioned that the O-alkylation of 10 requires a reactive bromide, like allylbromide (eventually benzylbromide, ethylbromoacetate), due to the lower nucleophilicity of the p-nitrophenolate units, while usual alkyl bromides are not reactive enough in the presence of Cs2CO3. However, the first ether residue can be chosen more or less freely,34 and the allyl group is easily hydrogenated to the propyl group.
The two different precursors of the amino function in 15 point (in pairs) in one or the other direction. The molecule has C2v-symmetry. An alternative to differentiate between amino functions attached to the wide rim consists in a partial protection by Boc. When 1 mol of tetraamine3518 is treated with 1.9 mol of Boc-anhydride (Scheme 3), 58% of the 1,2-diprotected derivative 20 can be isolated by chromatography, in addition to 23% of the monoprotected compound 19. (The yield of 20 can be increased to 65% and decreased to 18% for 19 using 2 mol of Boc-anhydride). If 3 mol of Boc-anhydride are used, the triprotected compound 22 is available in 63% yield from 18, and the tetra-Boc protected compound was formed as a side product. Similar to the cone-derivative the formation of a 1,3-diprotected 21 compound is not observed.
![]() | ||
Scheme 2 (i) Allylbromide, Cs2CO3, DMF, 50 °C; (ii) H2, Raney-Ni, EtOH, rt; (iii) phthalic anhydride, toluene, reflux; (iv) HNO3, CH2Cl2/AcOH; (v) hydrazine, EtOH, reflux; (vi) H2, Raney-Ni, toluene/THF, rt. |
Compound 20 is chiral (C2-symmetry), an aspect which is not further discussed in this article and the two protected, as well as the not-protected, amino functions point in different directions which contrasts to 15. Tetraamides with two different amide functions are available from 20 by acylation, deprotection and a second acylation as shown for one example. The acylation of 20 with acetanhydride leads quantitatively to 24 which after deprotection is easily acylated to tetraamide 25.
A possible reaction sequence to achieve this goal is shown in Scheme 4:
![]() | ||
Scheme 3 (i) 2 mol Boc2O; (ii) 3 mol Boc2O; (iii) Ac2O; (iv) CF3COOH, CHCl3, 0 °C; (v) p-nitrobenzoylchloride, CHCl3, NEt3, rt. |
Ipso-nitration of the syn-1,3-diether 2, followed by O-alkylation of 26 with allylbromide leads to compounds 27 in a reaction sequence analogous to Scheme 3.
The crucial step of the sequence, the O-alkylation with allylbromide (compare Scheme 2, step (i)), was tried under different conditions in the presence of Cs2CO3. While the reaction is too slow at room-temperature, an increase of the temperature favours the formation of the partial cone conformation over the desired 1,3-alternate. The best results in our hands were found for a concentrated reaction mixture (base and calixarene) in DMF at 40–50 °C for 5–7 days. A higher yield of 27 was obtained for n = 4 (53%) than for n = 3 (19%). This may be due to some steric hindrance between the phthalimido groups and the nitro groups of the inverted phenolic units, which is more pronounced for the shorter chains (n = 3 vs.n = 4). This could also explain why the partial cone (19%) and cone (2%) conformers were isolated as side products in the case of 27 (n = 3) while the formation of the partial cone conformer was detected only by NMR for 27 (n = 4).
![]() | ||
Scheme 4 (i) HNO3, CH2Cl2/AcOH; (ii) allylbromide, Cs2CO3, DMF, 40–50 °C; (iii) H2, Raney-Ni, THF, rt; (iv) hydrazine, EtOH, reflux; (v) hydrazine, Pd/C, EtOH, reflux. |
Compounds 27 again contain two independent precursors of amino functions. Catalytic hydrogenation leads to the wide rim diamines 28 (n = 3, 4) which can be N-acylated at the wide rim, deprotected and acylated again on the narrow rim to furnish a tetraamide with two different amide residues on the same side of the platform. Cleavage of the phthalimide groups by hydrazine in boiling ethanol leads to aliphatic diamines 30, as shown for n = 3 (57%), in which the nitro groups are retained. After a first N-acylation at the narrow rim, reduction of the nitro groups followed by a second acylation at the wide rim will lead to a mixed tetraamide again. The choice of the appropriate reaction sequence will be due to the acyl residues to be introduced.
The example of 30 (n = 3) shows that the allyl ether groups are converted to propyl ether groups during the hydrazinolysis of the phthalimide groups. After shorter reaction times products were isolated, in which all phthaloyl residues were cleaved, while allyl groups were still present. This suggests that conditions might be found under which the allyl groups remain unchanged, if this would be desired. However, up to now we could not obtain a pure compound 29.
Finally, a direct conversion of 27 into tetraamines 31 (R = H) should be also possible if the cleavage reaction with hydrazine is done in the presence of Pd/C (compare the preparation of 36 below). The resulting tetraamines show (in the case of n = 4) very broad 1H-NMR signals under all conditions studied, and also the unambiguous characterization as tetraacetamide 31 (R = COCH3) failed so far.36
![]() | ||
Scheme 5 (i) Alkylbromide, Cs2CO3, THF reflux or DMF 50 °C; (ii) HNO3, CH2Cl2/AcOH; (iii) H2, Raney-Ni, THF/DMF, 50°; then Ac2O; (iv) hydrazine, EtOH, reflux; (v) hydrazine, Pd/C, EtOH, reflux. |
The tetraether 32 (n = m = 3) can be obtained from the respective syn-1,3-diether 2 or directly in one step from 1. The two step synthesis makes it possible also to have two different spacer lengths n and m, as shown for 32 (n = 4, m = 3), which is obtained in 60% yield starting from 1,3-syn-diether 2 (n = 4), while the yield was lower for 32 (n = m = 3) (compare the synthesis of 27 discussed above). Ipso-nitration yields 33 (64%), a compound again containing two independent precursors for amino functions. The catalytic hydrogenation of the nitro groups (Raney-Ni, H2) was complicated by the low solubility of 33 (n = m = 3) in usual solvents or solvent mixtures, and 34 (R = H) was directly acylated and characterised as the tetraacetamide 34 (R = COCH3). Cleavage of the phthalimido groups in 33 led to the narrow rim tetraamine 35 and simultaneous reduction of the nitro groups (hydrazine, Raney-Ni) gave octaamine 36
As already mentioned, the formation of tetraethers in the 1,3-alternate conformation starting with syn-1,3-diethers 2 is usually accompanied by partial cone and cone isomers as side products.37 With calixarenes (e.g.1) as starting material the 1,2-alternate conformer must be considered additionally as a potential product which was isolated in the case of 32 (n = m = 3) in 31%.
In the following we will discuss typical examples proceeding mainly in the sequence given by Schemes 1 to 5. In many cases the molecular structure was additionally proved by X-ray analysis, for which some characteristic examples are presented the next section.
Due to the different ether residues in 4 the methylene protons are not identical and appear as a pair of doublets (AB system, J = 13.8 Hz) at δ = 3.86 and 3.78 ppm. The 1,3-alternate conformation follows nevertheless unambiguously from the small difference in their chemical shift (Δδ = 0.08 ppm), since a cone conformation would require a difference of about 1.2 ppm, and a partial cone conformer would not show a single pair of doublets. For ArH protons, the 1H-NMR displays two close singlets at 6.97 and 7.00 ppm, respectively. Two singlets are also found for t-Bu protons at 1.20 and 1.28 ppm. More pronounced are the differences in the chemical shift for the methylene protons in compound 11 (Δδ = 0.13 ppm), while two strongly separated singlets at 6.96 and 7.95 ppm for aromatic protons are due to the different substituents at the wide rim (t-Bu vs. NO2).
Two 1H-NMR spectra measured in CDCl3 and C6D6 are required for the complete identification of the chiral C2-symmetry of compound 20, where a two-fold axis intersects the carbon atoms of two opposite methylene bridges. Two singlets (3.28, 3.41 ppm) and a pair of doublets (3.32, 3.37 ppm) for the methylene protons are found in CDCl3. Two AB systems for the aromatic protons of 20 (doublets at 6.45/6.47 and 7.23/7.27 ppm) are shown only in C6D6, while this clear splitting cannot be seen in CDCl3. The compounds 19 and 22 show a similar pattern of signals reflecting the same Cs-symmetry in both cases, with the symmetry plane intersecting two opposite phenolic units (protected and unprotected).
Even a small difference in the length of the ether chains is reflected in the 1H-NMR spectrum of 32 (n = 3, m = 4). While the D2d-symmetrical compound 32 (n = m = 3) shows one singlet for the protons of the methylene bridges (3.67 ppm) and one for the aromatic protons (6.92 ppm), two doublets with geminal coupling (∼3.67, 3.70 ppm) for methylene protons and two close singlets (6.91, 6.96 ppm) for the aromatic protons are found for 32 (n = 3, m = 4), where the symmetry is reduced to C2v
The proton signals displayed in 1H-NMR spectrum show that all further amines (34, 35 and 36) generated from the 33 precursor have the same D2d-symmetry indicated by the presence of two singlets, one for methylene protons and the other one for the aromatic protons.
![]() | ||
Fig. 1 General atomic numbering scheme illustrated by 27 (n = 3). |
![]() | ||
Fig. 2 Molecular conformation of four calix[4]arenes: (a) 27 (1,3-alt, n = 3); (b) 27 (cone, n = 3); (c) 27 (1,3-alt, n = 4); (d) 11 (paco). |
![]() | ||
Fig. 3 The packing diagram of (a) 27 (1,3-alt, n = 3); (b) 27 (cone, n = 3); (c) 27 (1,3-alt, n = 4). |
For all compounds bond lengths and bond angles are in the usual range, and the following discussion refers mainly to the shape of the calixarene skeleton. A general and unambiguous description of the conformation of calixarenes is possible, using the torsion angles around the σ-bonds connecting the methylene bridges and the aromatic units (Table 1). The conformation of a given calix[4]arene is characterised by a typical sequence of the signs of these torsion angles, and these sequences are found for all compounds: (+,−)(+,−)(+,−)(+,−) for a cone conformation (27 (cone, n = 3)), (−,−)(+,+)(−,−)(+,+) for 1,3-alternate (27 (1,3-alt)), and (+,−)(+,−)(−,−)(+,+) for a partial cone (11 (paco)).40 While all torsions are in the range of 60° to 69° (absolute values) for 27 (1,3-alt, n = 3), smaller values down to 37° are found for 27 (1,3-alt, n = 4). To visualize the consequences for the shape of these two molecules in the 1,3-alternate conformation, and in general for a more vivid description of the conformation of calix[4]arenes the inclination of the single phenolic units with respect to a reference plane, the best plane through the four methylene carbon atoms (C1–C4), may be used. These δ values41 are also included in Table 1. Surprisingly the strongest deviation from an ideal regular square for C1–C4 is observed for the compound in the cone conformation. The two diagonals differ by about 0.74 Å, and pairs of opposite sides differ by 0.14 Å. Also the average deviation from the best plane (0.23 Å) is significantly higher than for the other three compounds (≤ 0.06 Å). Small but still significant differences are even found for the two molecules in the 1,3-alternate conformation, where the average side length for n = 4 is larger by 0.04 Å, compared with the analogue with n = 3.
(a) | (b) | (c) | (d) | |
---|---|---|---|---|
I. Torsion angles | ||||
C12–C11–C1–C43 | −60.5 | 66.8 | −46.6 | −112.7 |
C11–C1–C43–C42 | −69.3 | −115.4 | −54.5 | 74.8 |
C22–C21–C2–C13 | 65.5 | 136.6 | 68.4 | 61.3 |
C21–C2–C13–C12 | 61.8 | −78.4 | 37.2 | 58.9 |
C32–C31–C3–C23 | −60.2 | 61.3 | −45.2 | −70.0 |
C31–C3–C23–C22 | −64.1 | −113.6 | −61.0 | −59.9 |
C42–C41–C4–C33 | 68.5 | 133.2 | 60.3 | −69.9 |
C41–C4–C33–C32 | 60.3 | −71.1 | 46.6 | 119.6 |
II. Reference planes C1–C4 | ||||
rmsd | 0.006 | 0.23 | 0.062 | 0.037 |
Distance C1–C2 | 5.060 | 4.962 | 5.129 | 5.077 |
Distance C2–C3 | 5.097 | 5.122 | 5.109 | 5.111 |
Distance C3–C4 | 5.059 | 4.988 | 5.112 | 5.061 |
Distance C1–C4 | 5.090 | 5.117 | 5.121 | 5.042 |
Distance C1–C3 | 7.182 | 7.471 | 7.306 | 7.131 |
Distance C2–C4 | 7.177 | 6.729 | 7.164 | 7.215 |
III. Inclination of the aromatic units(δ) | ||||
C11–C16 | 91.4 | 134.4 | 116.3 | 99.0 |
C21–C26 | 91.6 | 78.9 | 102.4 | 95.4 |
C31–C36 | 94.3 | 142.4 | 110.9 | 84.4 |
C41–C46 | 84.9 | 79.8 | 106.7 | 139.3 |
(a) 27 (1,3-alt, n = 3) (b) 27 (cone, n = 3) (c) 27 (1,3-alt, n = 4) (d) 11 (paco) |
For 27 (1,3-alt, n = 3) all δ-values are close to 90°, only one nitrophenol unit is bent 5.1° inward and one t-butylphenol unit 4.3° outwards. Rather different is the shape of 27 (1,3-alt, n = 4), where both the nitrophenol units (12.4°, 16.7°) and the t-butylphenol units (26.3°, 20.9°) are strongly bent outwards. This “deformation” of the ideal 1,3-alternate conformation cannot be due to an intramolecular influence of the spacer (consisting of four instead of three carbon atoms). Therefore it must be caused by packing effects (see below) and gives an example of how strong these effects can be.
27 (cone, n = 3) is found in an extremely pinched cone conformation, where both nitrophenol units are bent inwards (11.1°, 10.2°) and both t-butyl phenol units are bent outwards (44.4°, 52.4°). The partial cone compound 11 (paco) can be roughly described as containing structural elements of a 1,3-alternate (aromatic rings 1 to 3) and a pinched cone (aromatic rings 3 to 1) conformer. The deviation of the former rings from an orientation perpendicular to the reference plane is ≤9°. The orientation of the t-butylphenol units is nearly parallel; one of them is bent outwards (9°) and the other one bent inwards (5.6°). Both p-nitrophenol units in-between are outwards oriented by 5.4° and 49.3°, respectively.
Molecular conformations of all four compounds are shown in Fig. 2, while Fig. 3 shows a representative section of the packing for the three phthaloyl substituted compounds.
Intermolecular forces between neighbouring molecules comprise π–π stacking between phthaloyl residues and aromatic units of the calixarenes (mainly between nitrophenol ether units). However, the inspection of the packing of the two 1,3-alternate derivatives 27 (n = 3,4) did not give obvious reasons for the differences found in their conformation.
1H-NMR (300 MHz, CDCl3) δ 0.86, 1.25 (2s, 36H, t-Bu), 3.25, 4.19 (2d, 8H, 2J = 13.2 Hz, Ar–CH2–Ar), 4.24 (t, 4H, 3J = 6.6 Hz, -CH2–N), 4.42 (t, 4H, 3J = 6.9 Hz, O–CH2-), 6.69 (s, 4H, ArH), 6.77 (s, 2H, OH), 6.98 (s, 4H, ArH), 7.67–7.92 (m, 8H, Phth-H).
1H NMR (300 MHz, CDCl3) δ 1.20, 1.28 (2s, 36H, t-Bu), 1.32–1.42 (m, 8H, -CH2–CH2–CH2-), 1.86 (t, 4H, 3J = 7.5 Hz, -CH2–CN), 3.38 (t, 4H, 3J = 8.0 Hz, -CH2–N), 3.46, 3.52 (2t, 8H, 3J = 7.0, 6.63 Hz, O–CH2-), 3.86, 3.78 (2d, 8H, 2J = 13.8 Hz, Ar–CH2–Ar), 6.97, 7.00 (2s, 8H, ArH), 7.68–7.82 (m, 8H, Phth-H).
1H NMR (300 MHz, CDCl3) δ 1.01, 1.25, 1.27 (3s, 18/9/9H, t-Bu),1.74 (m, 2H, -CH2–CH2–CH2-), 1.89 (m, 2H, -CH2–CH2–CH2-), 2.11 (m, 4H, -CH2–CH2–CH2-), 2.57 (t, 4H, 3J = 7.0 Hz, -CH2–CN), 3.09 (d, 2H, 2J = 12.5 Hz, Ar–CH2–Ar), 3.30 (t, 4H, 3J = 7.3 Hz, -CH2–N), 3.55–3.88 (m, 12H, O–CH2-, Ar–CH2–Ar), 4.00 (d, 2H, 2J = 12.1 Hz, Ar–CH2–Ar), 6.67, 6.86 (2d, 4H, 2J = 2.2 Hz ArH), 7.01, 7.10 (2s, 4H, ArH), 7.68–7.84 (m, 8H, Phth-H).
1H NMR (300 MHz, CDCl3) δ 1.18–1.37 (m, 8H, -CH2–CH2–CH2-), 1.30, 1.31 (2s, 36H, t-Bu), 1.91 (t, 4H, 3J = 7.7 Hz. CH2–CN), 2.16 (bs, 4H, -NH2), 2.50 (t, 4H, 3J = 6.9 Hz, CH2–NH2), 3.45–3.50 (2t, 8H, -CH2–O), 3.85, 3.86 (2d, 8H, 2J = 17.3 Hz, Ar–CH2–Ar), 7.01, 7.03 (2s, 8H, ArH).
1H NMR (300 MHz, CDCl3) δ 1.13–1.41 (m, 8H, -CH2–CH2–CH2-), 1.25, 1.30 (2s, 36H, t-Bu), 1.88 (t, 4H, 3J = 7.3 Hz, CH2–CN), 1.94 (s, 6H, -CH3), 2.28–2.94 (m, 4H, -CH2–NH), 3.26 (t, 4H, 3J = 9.0 Hz, -CH2–O), 3.49 (t, 4H, 3J = 6.0 Hz, -CH2–O), 3.84 (s, 8H, Ar–CH2–Ar), 6.4 (bs, 2H, NH), 6.96, 7.01 (2s, 8H, ArH).
1H NMR (300 MHz, CDCl3) while most of the signals are broad signals characteristic signals for aromatic protons, -NH, and terminal methyl groups can be distinguished: δ 1.25 (bm, 48H, -CH2–CH2–CH2-, t-Bu), 1.91 (s, 6H, -CH3), 2.50–3.81 (bm, 28H, -CH2–NH2, -NH2, -CH2–O, Ar–CH2–Ar), 6.43 (bs, 2H, NH), 6.96 (bs, 8H, ArH).
1H NMR (300 MHz, CDCl3) δ 1.13–1.41 (m, 8H, -CH2–CH2–CH2-), 1.25, 1.30 (2s, 36H, t-Bu), 1.46 (m, 4H, -CH2–CH2–CH2-), 1.92 (s, 6H, -CH3), 2.28–2.94 (m, 4H, CH2–CH2–CH2), 3.19–3.33 (m, 12H, -CH2–O, -CH2–N), 3.82 (s, 8H, Ar–CH2–Ar), 6.2 (bs, 2H, NH), 6.89 (bs, 2H, NH), 6.94, 6.97 (2s, 8H, ArH), 7.94, 8.23 (2d, 8H, 4J = 8.8 Hz, ArH).
1H NMR (300 MHz, DMSO-d6) δ 1.13, 1.27 (2s + m, 48H, t-Bu, -CH2–CH2–CH2-), 1.97 (t, 4H, 3J = 7.3 Hz, -CH2–NH2), 3.05 (bs, 4H, N–CH2-), 3.40 (bm, 12H, -O–CH2-, -NH2), 3.78, 3.95 (2d, 8H, 2J = 16.5 Hz, Ar–CH2–Ar), 7.03, 7.09 (2s, 8H, ArH), 7.28–7.35 (m, 4H, Phth-H), 7.50, 7.62 (2d, 4H, 2J = 7.0 Hz, PhthCOOH-H), 10.29 (bs, 1H, -COOH).
1H-NMR (300 MHz, CDCl3)
δ 0.79 (t, 6H, 3J
= 7.7 Hz, -CH2–CH3), 1.21 (s, 18H, t-Bu), 1.45 (m, 4H, -CH2–CH2–CH3), 3.56 (t, 4H, 3J
= 7.7 Hz, O–CH2), 3.68, 3.81 (2d, 8H, 2J
= 15.0 Hz, Ar–CH2–Ar), 3.94 (d, 4H, 4J
= 5.1 Hz, CH2CH–CH2–O-), 5.05 (m, 4H, CH2
CH-), 5.70 (m, 2H, CH2
CH-), 6.96, 7.95 (2s, 8H, ArH).
1H-NMR (300 MHz, CDCl3)
δ 0.98 (m, 24H, t-Bu, -CH2–CH3), 1.89 (m, 4H, -CH2–CH3), 3.19 (d, 2H, 2J
= 12.9 Hz, Ar–CH2–Ar), 3.52 (m, 2H, O–CH2-), 3.64 (d, 2H, 2J
= 13.6 Hz, Ar–CH2–Ar), 3.77 (m, 2H, O–CH2), 3.83 (d, 2H, 2J
= 13.6 Hz, Ar–CH2–Ar), 4.08 (d, 2H, 2J
= 13.2 Hz, Ar–CH2–Ar), 4.16, 4.31 (2d, 4H, 4J
= 5.9 Hz, -O–CH2–CHCH2), 4.90, 5.29 (2m, 4H, -CH
CH2), 5.65, 6.07 (2m, 2H, -CH
CH2), 6.50, 6.87 (2d, 4H, 4J
= 2.2, 2.6 Hz, ArH), 8.02, 8.23 (2s, 4H, ArH)
1H-NMR (300 MHz, CDCl3) δ 0.68, 0.76 (2t, 12H, 3J = 7.3, 7.7 Hz, -CH2–CH3), 1.13–1.38 (m, 26H, t-Bu, -CH2–CH3), 3.23–3.71 (m, 12H, O–CH2-, -NH2), 3.68, 3.80 (2d, 8H, 2J = 15.4 Hz, Ar–CH2–Ar), 6.64, 6.91 (2s, 8H, ArH).
1H-NMR (300MHz, CDCl3) δ 0.58–0.67 (m, 12H, -CH2–CH3), 1.04 (m, 4H, CH3–CH2-), 1.28 (m, 22H, t-Bu, -CH2–CH3), 3.39 (m, 8H, O–CH2-), 3.84, 3.87 (2d, 8H, 2J = 16.5 Hz, Ar–CH2–Ar), 6.97, 7.12 (2s, 8H, ArH), 7.70 (m, 8H, Phth-H).
1H NMR (300 MHz, CDCl3) δ 0.80, 0.88 (2t, 6H, 3J = 7.3 Hz, -CH2–CH3), 1.03 (t, 6H, 3J = 7.3 Hz, -CH2–CH3), 1.17 (s, 9H, t-Bu), 1.66–1.91 (m, 8H, -CH2–CH2–CH3), 3.55 (d, 2H, 2J = 14.0 Hz, Ar–CH2–Ar), 3.61–3.83 (m, 12H, Ar–CH2–Ar, O–CH2-), 3.81 (t, 2H, 3J = 7.7 Hz, O–CH2-), 6.98 (s, 2H, ArH), 7.15, 7.20 (2d, 4H, 4J = 2.6 Hz, ArH), 7.47–7.57 (m, 8H, Phth-H), 7.94 (s, 2H, ArH).
1H NMR (300 MHz, CDCl3) δ 0.89, 1.07 (2t, 12H, 3J = 7.3 Hz, -CH2–CH3), 1.82 (m, 8H, -CH2–CH2–CH3), 3.68 (s, 8H, Ar–CH2–Ar), 3.74 (m, 8H, O–CH2-), 7.19 (s, 4H, ArH), 7.47–7.57 (m, 8H, Phth-H), 7.96 (s, 4H, ArH).
Dinitro compound 15 was obtained also from the mononitro compound 14 using similar conditions. Glacial acetic acid (1.97 ml) and fuming nitric acid (0.11 ml) were added to a stirred solution of 14 (0.37 g, 0.375 mmol) in CH2Cl2 (25 ml). The reaction was followed by tlc and stopped (the color of the solution had changed from black to yellow) by adding water (50 ml). The organic solution was washed several times with water, dried (MgSO4) and the solvent was removed under reduced pressure. Precipitation from CH2Cl2–CH3OH (20 ml, 1 : 1) gave 15 as yellow powder (0.3 g, 83%).
1H NMR (300 MHz, CDCl3) δ 0.69, 0.78 (2t, 12H, 3J = 7.3 Hz, -CH2–CH3), 1.30–1.43 (m, 8H, -CH2–CH2–CH3), 2.69 (bs, 4H, -NH2), 3.27, 3.35 (2t, 8H, 3J = 7.3 Hz, O–CH2), 3.65, 3.66 (2d, 8H, 2J = 15.4 Hz, Ar–CH2–Ar), 6.4, 6.93 (2s, 8H, ArH).
1H NMR (400 MHz, DMSO-d6) δ: 0.52, 0.71 (2t, 12H, 3J = 7.4 Hz, -CH2–CH3), 1.17–1.24 (m, 8H, -CH2–CH2–CH3), 3.12 (bt, 4H, O–CH2-), 3.20 (bs, 4H, O–CH2-), 3.64, 3.72 (2d, 8H, 2J = 15.6 Hz, Ar–CH2–Ar), 4.33 (bs, 4H, -NH2), 6.28, 7.07 (2s, 8H, ArH), 7.88, 7.91 (2bs, 8H, Phth-H).
Mono-Boc derivative 19: pink powder, mp 138–140 °C (Found: C 71.34, H 7.90, N 6.53 C44H58N4O6 requires C 71.52, H 7.91, N 7.58)
1H NMR (300 MHz, CDCl3) δ 0.87–1.24 (m, 12H, -CH2–CH3), 1.50 (s, 9H, t-Bu), 1.86 (m, 8H, -CH2–CH2–CH3), 3.11–3.6 (m, 22H, Ar–CH2–Ar, O–CH2-, Ar–NH2), 6.34, 6.44 (2s, 4H, ArH), 6.98 (bs, 4H, ArH).
Di-Boc derivative 20: yellow powder, mp 251 °C (Found: C 70.21, H 7.71, N 6.56 C49H66N4O8 requires C 70.14, H 7.93, N 6.68)
1H NMR (400 MHz, C6D6) δ 0.99 (t, 12H, 3J = 7.3 Hz, -CH2–CH3), 1.66 (s, 18H, t-Bu), 1.71 (m, 8H, -CH2–CH2–CH3), 2.94 (bs, 4H, -NH2), 3.42–3.55 (m, 16H, Ar–CH2–Ar, O–CH2-), 6.45, 6.47 (2d, 4H, 4J = 2.9 Hz, ArH), 7.23, 7.27 (2d, 4H, 4J = 2.4 Hz, ArH), 7.5 (bs, 2H, -NH).
1H NMR (400 MHz, CDCl3) δ 1.10–1.29 (bm, 12H, -CH2–CH3), 1.48 (s, 18H, t-Bu), 1.87 (m, 8H, -CH2–CH2–CH3), 3.28 (s, 2H, Ar–CH2–Ar), 3.32 (d, 2H, 2J = 12.5 Hz, Ar–CH2–Ar), 3.37 (d, 2H, 2J = 13.0 Hz, Ar–CH2–Ar), 3.41 (s, 2H, Ar–CH2–Ar), 3.57–3.65 (m, 12H, O–CH2-, -NH2), 6.44, 6.93, 6.95 (3s, 4/2/2H, ArH), 7.82 (bs, 2H, -NH).
1H NMR (300 MHz, CDCl3) δ 0.98, 1.12 (2t, 12H, 3J = 7.3 Hz. -CH2–CH3), 1.50, 1.52 (2s, 18/9H, t-Bu), 1.59, 1.73 (2m, 4H, -CH2–CH2–CH3), 1.91 (m, 4H, -CH2–CH2–CH3), 3.33–3.69 (m, 18H, O–CH2, Ar–CH2–Ar, NH2), 6.14, 6.56 (2s, 1/2H, NH), 6.95, 6.98 (2s, 6/2H, ArH).
The tetra-Boc derivative 23 is formed as side product, but can be obtained in nearly quantitative yield, using 20–30% excess of Boc-anhydride. E.g., starting from a solution of tetraamino-calixarene 18 (1.0 g, 1.5 mmol) in CH2Cl2 (100 ml), pure tetra-Boc compound 23 (1.35 g, 90%) was obtained after purification by reprecipitation from CHCl3–hexane (1 : 5) as a white powder, mp 268–270 °C.
1H NMR (300 MHz, CDCl3) δ 0.80 (t, 12H, 3J = 7.3 Hz, -CH2–CH3), 1.44–1.53 (m, 8H, -CH2–CH2–CH3), 1.50 (s, 36H, t-Bu) 3.41 (t, 8H, 3J = 7.3 Hz, -CH2–CH2–CH3), 3.60 (s, 8H, Ar–CH2–Ar), 6.18 (s, 4H, -NH), 6.99 (s, 8H, ArH).
1H NMR (300 MHz, DMSO) δ 0.62 (bs, 12H, -CH2–CH3), 1.26 (bm, 26H, t-Bu, -CH2–CH2–CH3), 1.97 (s, 6H, -CO–CH3), 3.06 (bt, 8H, O–CH2-), 3.58 (bs, 8H, Ar–CH2–Ar), 7.16, 7.25 (2s, 8H, ArH), 8.93, 9.51 (2s, 4H, -NH-).
1H NMR (300 MHz, DMSO) δ 0.64 (m, 12H, -CH2–CH3), 1.31 (bm, 8H, -CH2–CH2–CH3), 1.95 (s, 6H, -CO–CH3), 3.2 (bt, 8H, O–CH2-), 3.66 (m, 8H, Ar–CH2–Ar), 7.37, 7.57 (2d, 8H, 4J = 3.7, 3.3 Hz, ArH), 8.11, 8.37 (2d, 8H, 4J = 8.8, 8.4 Hz, ArH), 9.55, 10.26 (2s, 4H, -NH-).
1H-NMR (300MHz, CDCl3) δ 0.9 (s, 18H, t-Bu), 3.41, 4.15 (2d, 8H, 2J = 13.2 Hz, Ar–CH2–Ar), 4.29 (t, 4H, 3J = 6.2 Hz, -CH2–N), 4.47 (t, 4H, 3J = 6.3 Hz, O–CH2-), 6.73 (s, 4H, ArH), 7.69–7.93 (m, 8H, Phth-H), 7.98 (s, 4H, ArH), 8.20 (s, 2H, OH).
1H NMR (200 MHz, CDCl3) δ 1.00 (s, 18H, t-Bu), 2.45 (m, 4H, -CH2–CH2–CH2), 3.48 (d, 4H 2J = 13.8 Hz, Ar–CH2–Ar), 4.11 (m, 8H, O–CH2-, -CH2–N), 4.30 (d, 4H, 2J = 13.8 Hz, Ar–CH2–Ar), 6.88 (s, 4H, ArH), 7.62–7.78 (m, 8H, Phth-H), 8.04 (s, 4H, ArH), 8.94 (s, 2H, -OH).
1H NMR (300 MHz, CDCl3) δ 1.01 (s, 18H, t-Bu), 2.10 (bs, 8H, -CH2–CH2–CH2), 3.44 (d, 4H 2J = 13.2 Hz, Ar-CH2–Ar), 3.89 (bt, 4H, -CH2–N), 4.06 (bt, 4H, O–CH2-) 4.21 (d, 4H, 2J = 13.2 Hz, Ar-CH2–Ar), 6.88 (s, 4H, ArH), 7.66–7.82 (m, 8H, Phth-H), 8.00 (s, 4H, ArH), 9.07 (s, 2H, OH).
1H-NMR (400 MHz, CDCl3)
δ 1.20 (s, 18H, t-Bu), 1.88 (m, 4H, -CH2–CH2–CH2-), 3.69 (m, 8H, O–CH2-, -CH2–N), 3.69, 3.81 (2d, 8H, 2J
= 15.6 Hz, Ar–CH2–Ar), 3.97 (d, 4H, 2J
= 9.7 Hz, CH2CH–CH2–O-), 5.03 (m, 4H, CH2
CH-), 5.70 (m, 2H, CH2
CH-), 6.95 (s, 4H, ArH), 7.74 (m, 8H, Phth-H), 7.99 (s, 4H, ArH).
1H-NMR (400 MHz, CDCl3)
δ 1.00, 1.24 (2s, 18H, t-Bu), 2.21 (m, 4H, -CH2–CH2–CH2-), 3.19, 3.68 (2d, 4H, 2J
= 12.9, 13.7 Hz, Ar–CH2–Ar), 3.88 (m, 8H, O–CH2-, -CH2–N), 3.90, 4.07 (2d, 4H, 2J
= 13.3, 12.9 Hz, Ar–CH2–Ar), 4.19, 4.24 (2d, 4H, 2J
= 6.3 Hz, -O–CH2–CHCH2), 4.89, 5.28 (2m, 4H, CH2
CH-), 5.54, 6.02 (2m, 2H, CH2
CH-), 6.35, 6.87 (2d, 4H, 4J
= 1.9 Hz, ArH), 7.83 (m, 8H, Phth-H), 8.05, 8.35 (2s, 4H, ArH).
1H-NMR (200 MHz, CDCl3)
δ 1.28 (s, 18H, t-Bu), 2.28 (m, 4H, -CH2–CH2–CH2-), 3.19 (d, 4H, 2J
= 13.6 Hz, Ar–CH2–Ar), 3.81 (t, 4H, 3J
= 7.3 Hz, -CH2–N), 4.07 (t, 4H, 3J
= 7.5 Hz, -CH2–O-), 4.38 (d, 4H, 2J
= 5.9 Hz, -O–CH2–CHCH2), 4.41 (d, 4H, 2J
= 13.6 Hz, Ar–CH2–Ar), 5.11 (m, 4H, CH2
CH-), 6.13 (m, 2H, CH2
CH-), 7.03, 7.12 (2s, 8H, ArH), 7.78 (m, 8H, Phth-H).
1H-NMR (300 MHz, CDCl3)
δ 1.20 (s, 18H, t-Bu), 1.55, 1.72 (2m, 8H, -CH2–CH2–CH2-), 3.69 (m, 8H, O–CH2-, -CH2–N), 3.62, 3.66 (2d, 8H, J
= 15.6 Hz, Ar–CH2–Ar), 3.97 (d, 4H, J
= 5.1 Hz, CH2CH–CH2–O-), 5.12 (m, 4H, CH2
CH-), 5.74 (m, 2H, CH2
CH-), 6.95 (s, 4H, ArH), 7.67 (m, 8H, Phth-H), 7.99 (s, 4H, ArH).
1H-NMR (200 MHz, CDCl3) δ 0.58 (t, 6H, 3J = 7.3 Hz, CH3–CH2-), 1.04–1.18 (m, 22H, CH3–CH2–CH2-, t–Bu), 1.55 (m, 4H, -CH2–CH2–CH2-), 3.18 (bt, 4H, 3J = 6.8 Hz, -CH2–N), 3.33–3.3.45 (bm, 12H, O–CH2-, -NH2), 3.57, 3.68 (2d, 8H, 2J = 15.5 Hz Ar–CH2–Ar), 6.38 (s, 4H, ArH), 6.88 (s, 4H, ArH), 7.59–7.76 (bm, 8H, Phth-H)
1H-NMR (300MHz, CDCl3) δ 0.65 (t, 6H, 3J = 7.7 Hz, CH3–CH2-), 1.03–1.46 (m, 26H, -CH2-, t-Bu), 1.81 (m, 4H, -CH2-), 3.18–3.69 (m, 24H, -CH2–N, O–CH2-, -NH2, Ar–CH2–Ar), 6.40, 6.92 (2s, 8H, ArH), 7.67–7.80 (bm, 8H, Phth-H).
1H-NMR (300 MHz, CDCl3) δ 0.79 (t, 6H, 3J = 7.3 Hz, -CH2–CH3), 1.23 (s, 18H, t-Bu) 1.39–1.58 (m, 8H, -CH2-), 2.64 (t, 4H,3J = 7.0 Hz -CH2–NH2), 3.50 (t, 4H, 3J = 7.3 Hz, O–CH2-) 3.66–3.73 (m, 8H, O–CH2-, Ar–CH2–Ar), 3.84 (d, 4H, 2J = 15.0 Hz Ar–CH2–Ar), 6.89, 7.98 (2s, 8H, ArH).
1H-NMR (200 MHz, CDCl3) δ 1.15 (s, 36H, t-Bu), 1.67 (m, 8H, -CH2–CH2–CH2-), 3.44 (t, 8H, 3J = 7.8 Hz, -CH2–N), 3.62 (t, 8H, 3J = 6.8 Hz, -CH2–O), 3.67 (s, 8H, Ar–CH2–Ar), 6.92 (s, 8H, ArH), 7.65–7.82 (m, 16H, Phth-H).
1H-NMR (200 MHz, CDCl3) δ 1.05 (m, 4H, -CH2–CH2–CH2-) 1.26 (s, 36H, t-Bu), 1.60 (m, 4H, -CH2–CH2–CH2-), 3.00 (d, 2H, 2J = 12.1 Hz, Ar–CH2–Ar), 3.54–3.87 (m, 16H, -CH2–N, -CH2–O), 3.88 (s, 4H, Ar–CH2–Ar), 4.07 (d, 2H, 2J = 12.1 Hz, Ar–CH2–Ar), 7.05, 7.09 (2d, 8H, 2J = 2.2 Hz, ArH), 7.51–7.66 (m, 16H, Phth-H).
1H-NMR (200 MHz, CDCl3) δ 0.95, 1.25, 1.28 (3s, 18/9/9H, t-Bu), 1.87, 2.09, 2.22 (3m, 2/2/4H, -CH2–CH2–CH2-), 2.99 (d, 2H, 2J = 8.5 Hz Ar–CH2–Ar), 3.54–3.87(m, 20H, -CH2–N, -CH2–O, Ar–CH2–Ar), 4.01 (d, 2H, 2J = 8.3 Hz, Ar–CH2–Ar), 6.53, 6.78 (2d, 4H, 4J = 1.4, 2.5 Hz, ArH), 7.02, 7.17 (2s, 4H, ArH), 7.52–7.71 (m, 16H, Phth-H).
1H-NMR (300 MHz, CDCl3) δ 1.18, 1.19 (2s, 36H, t-Bu), 1.32, 1.71 (2m, 16H, -CH2–CH2–CH2-), 3.38–3.66 (m, 20H, O–CH2-, -CH2–N Ar–CH2–Ar), 3.70 (d, 4H, 2J = 16.53 Hz Ar–CH2–Ar), 6.91, 6.96 (2s, 8H, ArH), 7.66–7.83 (m, 16H, Phth-H).
1H-NMR (400 MHz, C6D6) δ 1.39, 1.41 (2s, 36H, t-Bu), 1.59, 1.86 (2m, 8H, -CH2–CH2–CH2-), 3.38 (t, 4H 3J = 7.4 Hz, -CH2–N), 3.57–3.66 (m, 12H, O–CH2-, -CH2–N), 3.87, 3.92 (2d, 8H, 2J = 15.6 Hz Ar–CH2–Ar), 6.86–6.88 (m, 8H, Phth-H), 7.11, 7.26 (2s, 8H, ArH), 7.46–7.49 (m, 8H, Phth-H).
1H NMR (200 MHz, CDCl3) δ 2.26 (m, 8H, -CH2–CH2–CH2-), 3.84 (s, 8H, Ar–CH2–Ar), 3.95 (m, 16H, -CH2–N, O–CH2-), 7.68–7.86 (m, 16H, Phth-H), 8.06 (s, 8H, ArH).
1H NMR (400 MHz, CDCl3) δ 2.19 (bm, 20H, CH2–CH2–CH2-, -CH3), 3.45 (s, 8H, Ar–CH2–Ar), 3.79 (t, 8H, 3J = 4.7 Hz, O–CH2-), 4.24 (t, 8H, 3J = 7.8 Hz, -CH2–N), 7.36 (s, 8H, ArH), 7.70–7.81 (m, 16H, Phth-H), 8.09 (s, 4H, NH).
1H NMR (200 MHz, CDCl3) δ 1.85 (m, 16H, -NH2, -CH2–CH2–CH2-), 2.79 (t, 8H, 3J = 6.3 Hz, -CH2–N), 3.53 (s, 8H, Ar–CH2–Ar), 3.78 (t, 8H, 3J = 6.5 Hz, O–CH2-), 7.78 (s, 8H, ArH).
1H NMR (300 MHz, CDCl3) δ 1.98–2.06 (m, 8H, -CH2–CH2–CH2-), 3.00 (t, 8H, 3J = 6.6 Hz, -CH2–N), 3.73 (s, 8H, Ar–CH2–Ar), 3.98 (t, 8H, 3J = 6.6 Hz, O–CH2-), 8.00 (s, 8H, ArH).
Compound | 27 (1,3-alt, n = 3) | 27 (cone, n = 3) | 27 (1,3-alt, n = 3) | 11 (paco) |
---|---|---|---|---|
Formula | C64H64N4O12 | C64H64N4O12 | C67H70Cl2N4O12 | C48H58N2O8 |
M w | 1081.19 | 1081.19 | 1194.17 | 790.96 |
Crystal system | monoclinic | triclinic | triclinic | triclinic |
Space group | C2/c (No. 15) |
P![]() |
P![]() |
P![]() |
T/K | 173 | 173 | 173 | 100 |
a/Å | 16.7651(15) | 14.1953(7) | 13.4904(6) | 10.3423(7) |
b/Å | 29.395(3) | 14.6587(7) | 14.1373(7) | 13.1610(9) |
c/Å | 24.507(2) | 15.3671(7) | 17.7409(8) | 16.5605(7) |
α/° | 83.459(4) | 101.868(5) | ||
β/° | 95.993(7) | 92.666(4) | 69.464(4) | 96.988(5) |
γ/° | 76.454(4) | 91.968(5) | ||
V/Å | 12011.3(19) | 2923.2(2) | 3078.5(2) | 2185.5(3) |
Z | 8 | 2 | 2 | 2 |
µ/mm−1 | 0.083 | 0.085 | 0.171 | 0.081 |
Unique refins. Measured | 61211 | 62074 | 83961 | 31174 |
Unique refins.[I > 2σ(I)] | 11107 | 17077 | 14584 | 9295 |
wR(F2) | 0.3033 | 0.1492 | 0.3124 | 0.1077 |
One of the tert-butyl groups of 27 (cone, n = 3) is disordered over two positions with a ratio of the site occupation factors of 0.471(8) : 0.529(8). For 11 (paco) the tert-butyl groups are disordered over two positions with a ratio of the site occupation factors of 0.461(3) : 0.539(3) and 0.483(6) : 0.517(6), respectively and also, one of the methylene bridges is disordered over two positions with a ratio of the site occupation factors of 0.319(6) : 0.681(6). Residual electron densities: 27 (1,3-alt, n = 3) 1.89 e Å−3 at 0.5000, 0.1015, 0.2500, 27 (cone, n = 3) 1.02 e Å−3 at 0.4964, 0.2884, 0.0518, 27 (1,3-alt, n = 4) 3.00 e Å−3 at 0.8438, 0.0734, 0.2070. Crystallographic data in CIF format have been deposited with the Cambridge Crystallographic Data Centre: CCDC reference numbers 249854–249857. See http://www.rsc.org/suppdata/ob/b4/b414173c/ for crystallographic data in .cif or other electronic format.
This journal is © The Royal Society of Chemistry 2005 |